These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17179612)

  • 1. Antiretroviral therapy: need for a long-term view.
    Maniar JK
    Indian J Dermatol Venereol Leprol; 2006; 72(6):401-4. PubMed ID: 17179612
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of anti-retrovirals in pediatric HIV infection.
    Gaur S
    Indian J Dermatol Venereol Leprol; 2008; 74(3):208-14. PubMed ID: 18583784
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective drug taking during combination antiretroviral therapy.
    Lanzafame M; Melotti R; Lattuada E; Boccafoglio F; Concia E; Verlato G; Vento S
    J Acquir Immune Defic Syndr; 2007 Apr; 44(4):490-1. PubMed ID: 17353720
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of antiretroviral therapy in low-resource settings.
    Bendavid E
    Lancet; 2008 Jul; 372(9635):288-9; author reply 289. PubMed ID: 18657700
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood lipid changes at long-term antiretroviral treatment].
    Snopková S; Jarkovský J; Matýsková M; Povolná K; Polák P; Cvanová M; Husa P
    Vnitr Lek; 2011 May; 57(5):463-71. PubMed ID: 21695927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationing antiretroviral therapy in Africa--treating too few, too late.
    Ford N; Mills E; Calmy A
    N Engl J Med; 2009 Apr; 360(18):1808-10. PubMed ID: 19403900
    [No Abstract]   [Full Text] [Related]  

  • 7. Initiating HIV therapy. Timing is critical, controversial.
    Volberding PA
    Postgrad Med; 2004 Feb; 115(2):15-8, 21, 24-6. PubMed ID: 15000057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A wake-up call for global access to salvage HIV drug regimens.
    Mills EJ; Nachega JB
    Lancet; 2007 Dec; 370(9603):1885-7. PubMed ID: 18068497
    [No Abstract]   [Full Text] [Related]  

  • 9. [Yes, simplify antiretroviral treatments, but not at a significant price!].
    Casalino E
    Med Mal Infect; 2005 Apr; 35 Suppl 1():S11-4. PubMed ID: 15922875
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic drug monitoring: pharmacologic considerations for antiretroviral drugs.
    Kiser JJ; Anderson PL; Gerber JG
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):61-7. PubMed ID: 16091250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaling up antiretroviral treatment in resource-poor settings.
    Batz HG; Guillerm M; Gonsalves G
    Lancet; 2006 Aug; 368(9534):445. PubMed ID: 16890819
    [No Abstract]   [Full Text] [Related]  

  • 12. Should antiretroviral therapy be started earlier?
    Gallant JE
    Curr HIV/AIDS Rep; 2007 May; 4(2):53-9. PubMed ID: 17547825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "High" antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART.
    Lanzafame M; Piacentini D; Lattuada E; Rizzardo S; Chiesi S; Vento S
    Infect Dis (Lond); 2018 Oct; 50(10):788-790. PubMed ID: 29916752
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral therapy options for treatment-naive patients with HIV-1.
    Hedley L; Minton J; Wallis G; Waters L
    Br J Hosp Med (Lond); 2015 Aug; 76(8):C122-5. PubMed ID: 26255930
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of serum levels of antiretroviral drugs].
    Kurowski M
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():62-4. PubMed ID: 15373053
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study.
    Ledergerber B; Cavassini M; Battegay M; Bernasconi E; Vernazza P; Hirschel B; Furrer H; Rickenbach M; Weber R;
    HIV Med; 2011 May; 12(5):279-88. PubMed ID: 20955356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial treatment of HIV-1 infection.
    Nicastri E; Narciso P; Andreoni M
    N Engl J Med; 2008 Aug; 359(9):970-1; author reply 971. PubMed ID: 18763319
    [No Abstract]   [Full Text] [Related]  

  • 18. Adherence to first-line antiretroviral regimens in Rwanda.
    Demeester R; Omes C; Karasi JC; Schneider S; Mugabo J; Maliboli MJ; Arendt V
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):113-4. PubMed ID: 16123694
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.
    Kekitiinwa A; Asiimwe AR; Kasirye P; Korutaro V; Kitaka S; Maganda A; Madalon M; Graziano FM
    Pediatr Infect Dis J; 2012 Aug; 31(8):e117-25. PubMed ID: 22581223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.